Companion diagnostics has captured the public imagination, and there is no doubt that its role and importance in clinical research, diagnosis, and prescriptions will continue to grow. For professionals seeking business intelligence on this sector, Espicom Ltd. has published a comprehensive guide that informs on business trends, the sometimes murky regulatory framework under which companion diagnostics are governed, and relevant current and potential pharmaceutical products.
The Complete Guide to Companion Diagnostics: Market Environment, Products and Companies provides the following insights, according to the publisher:
The report costs $1740. For more information, go to the Espicom website.